Niagen Bioscience (NAGE) Total Non-Current Liabilities (2011 - 2020)

Niagen Bioscience (NAGE) has 8 years of Total Non-Current Liabilities data on file, last reported at $20.2 million in Q2 2020.

• On a quarterly basis, Total Non-Current Liabilities fell 30.73% year-over-year to $20.2 million in Q2 2020; TTM through Jun 2020 was $20.2 million, a 30.73% decrease from a year earlier, with the FY2019 full-year figure at $19.6 million, up 32.84% from the prior year.
• Total Non-Current Liabilities for Q2 2020 stood at $20.2 million, up from $18.8 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for NAGE reached as high as $29.1 million in Q2 2019 and fell as low as $6.6 million in Q4 2016.
• Historically, Total Non-Current Liabilities has averaged $14.0 million across 5 years, with a median of $13.2 million in 2016.
• Across the five-year window, Total Non-Current Liabilities soared 153.45% in 2019 and plunged 30.73% in 2020, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $9.4 million in 2016, then retreated by 8.66% to $8.6 million in 2017, then surged by 72.33% to $14.8 million in 2018, then jumped by 32.84% to $19.6 million in 2019, then grew by 2.69% to $20.2 million in 2020.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $20.2 million in Q2 2020, $18.8 million in Q1 2020, and $19.6 million in Q4 2019.